Key result
Central administration of the apelin antagonist F13A restored delayed gastric emptying following acute restraint stress and chronic complicated stress in rats.
Why the study?
Does central administration of apelin antagonist F13A restore delayed gastric emptying following acute and chronic complicated stress in rats?
Does central administration of apelin antagonist F13A restore delayed gastric emptying following acute and chronic complicated stress in rats?
Central apelin contributes to stress-induced delayed gastric emptying, suggesting apelin antagonism could be a potential therapeutic target for stress-induced gastrointestinal disorders.
Apelin antagonism may target stress-induced gastroparesis; animal data leave clinical translation open.
Stress plays a major role in functional gastrointestinal (GI) disorders. GI symptoms may develop as a result of accumulation stressors in some individuals while others can adapt to stressors. Exposure to repeated experience with the same stressor can produce an adaptation of behavioral and hypothalamic‐pituitary‐adrenal (HPA) axis response. However, the adaptation mechanism remains unclear. Acute restraint stress (ARS) increases corticotrophin releasing factor (CRF) in hypothalamic paraventricular nucleus (PVN) leads delayed gastric emptying (GE) via autonomic neural pathways in rats. ARS‐induced delayed GE is completely restored following chronic single stress (CSS) while restoration is no longer observed following chronic complicated stress (CCS). Apelin is upregulated in PVN in response to stress. Central effects of apelinergic system are attributed to regulation of stress response. We performed GE measurement and brain microdialysis from PVN under non‐stressed, ARS, CSS and CCS conditions in rats. ARS significantly increased CRF and apelin concentrations. CSS attenuated this response, whilst concentrations remained significantly high following CCS. ARS delayed GE which was completely restored following CSS, but not CCS. Central administration of apelin antagonist F13A restored delayed GE following ARS and CCS. Thus, apelin may be a candidate for treatment of stress‐induced GI disorders.
No takes yet. Share an insight, caveat, or question.
Bülbül et al. (2013) studied Stress-induced impaired gastric motility. Central administration of apelin antagonist F13A vs. Non-stressed, ARS, CSS, and CCS conditions was evaluated on Gastric emptying and CRF/apelin concentrations. Central administration of the apelin antagonist F13A restored delayed gastric emptying following acute restraint stress and chronic complicated stress in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: